Klotho Neurosciences (KLTO) Narxning foydaga nisbati
Klotho Neurosciences Inc (KLTO) rivojlanishi Klotho proteinini qo'llash bo'yicha noyob patentlarga va FDA qat'iy nazoratiga tayanadi. Dorilarni yetkazib berish transport jarayonida harorat nazoratiga qat'iy rioya qilishga asoslangan. -3.10 ko'rsatkichi bo'lgan aktivning bozor qiymati dinamikasi brendning miya qarishiga qarshi muolajalar bo'yicha yetakchi ishlab chiquvchi maqomini ta'kidlaydi, bu esa tibbiyot hamjamiyati orasida katta qiziqish uyg'otmoqda.
Klotho Neurosciences Inc kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi haqida ma'lumot:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Klotho Neurosciences Inc|KLTO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati ANEW Medical, Inc.|KLTO - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Klotho Neurosciences Inc|KLTO - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Klotho Neurosciences|Shoshilinch likvidlik anewmeds.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
KLTO - Sof daromad|Prognoz qilingan kelajakdagi foyda Klotho Neurosciences Inc|KLTO - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori ANEW Medical, Inc.|KLTO - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Klotho Neurosciences Inc|KLTO - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Klotho Neurosciences|KLTO - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi anewmeds.com|KLTO - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Klotho Neurosciences Inc
Kompaniyaning umumiy tahlili:anewmeds.com - KLTO
Neurodegenerativ kasalliklar terapiyasida ustunlikka intilayotgan Klotho Neurosciences Inc (KLTO) uchun ushbu ko'rsatkich kelajakdagi ishlanmalarning monetizatsiyasiga oid bozor kutuvlarini aks ettiradi. Kompaniyaning P/E koeffitsiyenti tarixini tahlil qilish orqali investor kelajakdagi daromadlar uchun joriy premiumni baholaydi, bu esa kapitalizatsiyaning makroiqtisodiy zarbalarga va neyrofarmatsevtika sektoridagi tartibga soluvchi o'zgarishlar risklariga nisbatan zaifligini aniqlash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
P/E multiplikatori biogen.com|Narxning foydaga nisbati Neurocrine Biosciences, Inc. (NBIX)|Narxning foydaga nisbati RGC (Regencell Bioscience Ltd)|Narxning foydaga nisbati Axsome Therapeutics Inc AXSM|ACADIA Corp (ACAD) - Kapitalizatsiyaning foydaga nisbati|XENE: Narx-foyda koeffitsiyenti|vikingtherapeutics.com - Bozor narxining sof foydaga nisbati|SUPN: P/E multiplikatori|Catalyst Pharma - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Denali Therapeutics Inc|Kapitalizatsiyaning foydaga nisbati Harmony Corp HRMY|Narx-foyda koeffitsiyenti BHVN (Biohaven Ltd.)|AMLX (amylyx.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|PRAX: Narx-foyda multiplikatori|Anavex Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CeriBell EEG|PRTA (prothena.com) - Narx-foyda koeffitsiyenti|Alector (ALEC) - P/E multiplikatori|Narxning foydaga nisbati Annexon|OMER: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Neurogene Corp (NGNE)|ACIU - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Voyager Therapeutics VYGR|Biznesning o‘zini qoplash muddati neumoratx.com (NMRA)|Scilex - P/E multiplikatori|Tevogen Bio Holdings Inc. (TVGN) - Narx-foyda koeffitsiyenti|ACOG: P/E multiplikatori|CGTX - Biznesning o‘zini qoplash muddati|IKT (Inhibikase Therapeutics) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati cassavasciences.com SAVA|Narxning foydaga nisbati Assertio Holdings, Inc. (ASRT)|coyatherapeutics.com - Narx-foyda multiplikatori|P/E multiplikatori VTGN (Vistagen)|OVID - Narx-foyda koeffitsiyenti|Acumen Pharmaceuticals - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati cervomed.com|alteritytherapeutics.com (ATHE) - Narxning foydaga nisbati|CLNN - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti PEPG|JUNS: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori RLMD|Biznesning o‘zini qoplash muddati annovisbio.com|Narxning foydaga nisbati Grace Therapeutics GRCE|AIFF: Narx-foyda multiplikatori|NeuroSense Therapeutics, Ltd. - P/E multiplikatori|Reviva Pharmaceuticals, Inc. (RVPH) - Narx-foyda koeffitsiyenti|metaviatx.com (MTVA) - Narxning foydaga nisbati|neuraxis.com (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical Technologies, Inc.|Narxning foydaga nisbati PASG|Narx-foyda koeffitsiyenti NEUP (Neuphoria Therapeutics Inc.)|Bozor narxining sof foydaga nisbati NERV|Narxning foydaga nisbati Athira Pharma, Inc. ATHA|addextherapeutics.com (ADXN) - Kapitalizatsiyaning foydaga nisbati|ALZN - Narxning foydaga nisbati|CYCN (Cyclerion Therapeutics) - Narx-foyda multiplikatori|PTIX: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Pasithea Therapeutics Corp. (KTTA)|Narx-foyda koeffitsiyenti CRGT|P/E multiplikatori avenuetx.com|Narxning foydaga nisbati BrainStorm Cell Therapeutics (BCLI)|CARA (Cara Therapeutics Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Chromocell Therapeutics Corporation CHRO|Eliem Therapeutics, Inc. (ELYM) - Kapitalizatsiyaning foydaga nisbati|ITCI - Narxning foydaga nisbati|LBPH - P/E multiplikatori|Marinus Pharmaceuticals, Inc. (MRNS) - Narxning foydaga nisbati|NKGN (NKGen Biotech Inc) - Narxning foydaga nisbati|Narxning foydaga nisbati NeuroBo|Kapitalizatsiyaning foydaga nisbati Sage Therapeutics Inc SAGE|Narx-foyda koeffitsiyenti SNPX (Synaptogenix, Inc.)|Bozor narxining sof foydaga nisbati TRVN|P/E multiplikatori VIGL (Vigil Neuroscience, Inc.)|Kompaniya qiymatining sof foydaga nisbati WENA|CERE - Narxning foydaga nisbati
